<< Management Of Acute Asthma In The Pediatric Patient: An Evidence-Based Review

Controversies And Cutting Edge

Researchers are continuously seeking innovative ways to prevent, assess, and treat acute childhood asthma. A vaccine has recently been developed that may be effective in preventing acute asthma by targeting one of the most critical mediators of asthma pathology, interleukin-13 (IL-13).

To read the rest of this section, choose one of the options below.

Already purchased this course?
Log in to read.
Purchase a subscription

Price: $449/year

140+ Credits!

Money-back Guarantee
Get Quick-Read Evidence-Based Updates
Enter your email to get free evidence-based content delivered to your inbox once per month.
Please provide a valid email address.